@article{f8f7618de27f4ed98786207a7a0929a3,
title = "Intercontinental spread from Israel to Colombia of a KPC- 3- producing Klebsiella pneumoniae strain",
abstract = "In 2008, an increase in the prevalence of carbapenem- resistant Klebsiella pneumoniae was noted in a 286- bed tertiary case hospital in Colombia, where 84 patients (32 infected and 52 colonized) had positive cultures. The identified index patient came from Israel for a liver transplantation. High level carbapenem resistance was observed. Polymyxin B and tigecycline were the only two antibiotics that remained active. PCR- restriction fragment length polymorphism analysis and sequencing revealed blaKPC- 3 in the major clone, which was indistinguishable from the K. pneumoniae carbapenemase- 3- producing clone described previously in Israel. This exemplifies the threat posed by the global spread of K. pneumoniae carbapenemase- producing pathogens.",
keywords = "Colombia, Dissemination, Israel, KPC- 3, Klebsiella pneumoniae",
author = "Lopez, {J. A.} and A. Correa and {Navon- Venezia}, S. and Correa, {A. L.} and Torres, {J. A.} and Brice{\~n}o, {D. F.} and Montealegre, {M. C.} and Quinn, {J. P.} and Y. Carmeli and Villegas, {M. V.}",
note = "Funding Information: The conformation of the network of institutions from the Colombian Nosocomial Resistance Study Group and funding for this study were made possible thanks in part to the support of: AstraZeneca, Colombia; Pfizer Inc., Groton, CT; Merck Sharp & Dohme, Baxter, Colombia, Wyeth, Colombia,; and Janssen, Colombia. ",
year = "2011",
month = jan,
doi = "10.1111/j.1469-0691.2010.03209.x",
language = "אנגלית",
volume = "17",
pages = "52--56",
journal = "Clinical Microbiology and Infection",
issn = "1198-743X",
publisher = "Elsevier B.V.",
number = "1",
}
